Merck Presents New Long-Term Oncology Data at ASCO 2026
Merck, also known as MSD outside the US and Canada, announced new research findings from over 100 abstracts covering more than 25 cancer types. These findings highlight advancements in the company's extensive oncology portfolio and pipeline research presented at ASCO 2026.
Pharma Biz·


